BOCA RATON, FL -- (Marketwire) -- 05/16/12 -- MedeFile International, Inc. (MDFI) (MDFI), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, announced its financial results for the first quarter reporting period, ended March 31, 2012.

Financial Highlights for Three Months Ended March 31, 2012 Compared to Three Months Ended March 31, 2011:

• Revenues totaled $13,714, down 90% from $132,102. The decrease in revenues was largely attributable to the Company's shift in marketing strategy -- which occurred in mid-2011, providing for MedeFile to solely concentrate on winning large, wholesale opportunities with large medical practice groups and institutions, insurance companies, law firms, trade unions, affinity groups and other notable organizations capable of enrolling thousands of subscribers onto the MedeFile iPHR system simultaneously.
  
  
  • In April 2012, the Company announced its first major 90-day pilot program with Promise Healthcare, a leading national long-term acute hospital company employing 3,000 people.
    
    
  • MedeFile also reported in April that it signed Medical Specialists of the Palm Beaches, providing for MSPB's 75+ physicians to leverage their influence with their collective patient base of more than 200,000 people to encourage them to enroll in MedeFile as their personal health record management solution.
    
    
• Operating expenses declined 52%, decreasing to $247,371 from $516,820.
  
  
• Consequently, the net loss totaled $233,723, or $0.00 per basic and diluted share, representing a 48% decrease from a net loss of $448,193, or $0.00 per basic and diluted share.
  
  
• As of March 31, 2012, cash totaled $30,344; and there was zero long term debt. Subsequent to the end of the first quarter of 2012, MedeFile raised gross cash proceeds of $900,000 via three separate private placements. The first private equity transaction provided for the placement of 100,000 shares of Series B Preferred Stock for $100,000; the second transaction provided for the placement of 5,000,000,000 shares of common stock for an aggregate purchase price of $500,000; and the third transaction provided for the placement of 3,000,000,000 shares of common stock for an aggregate purchase price of $300,000.
  
  

For more detailed information relating to the Company's first quarter 2012 results and the noted private placement transactions completed subsequent to the end of the quarter, please refer to the financial statements included with this press release and the related disclosure documents, including the 10Q for the period ended March 31, 2012, filed with the US Securities & Exchange Commission at www.sec.gov.

FINANCIAL CHARTS FOLLOW

                        MEDEFILE INTERNATIONAL, INC.
                         CONSOLIDATED BALANCE SHEETS

                                                 Unaudited
                                                 March 31,     December 31,
Assets                                              2012           2011
                                               -------------  -------------
  Current assets
    Cash                                       $      30,344  $     198,173
    Accounts receivable, net                           1,893            617
  Inventory                                           53,859         53,925
    Merchant services reserve                         64,320         62,530
  Prepaid insurance                                        -          1,055
                                               -------------  -------------
  Total current assets                               150,416        316,300
    Website development, net of accumulated
     amortization                                     20,982         26,227
    Furniture and equipment, net of
     accumulated depreciation                          7,927         10,278
  Intangibles                                          1,339          1,339
                                               -------------  -------------
      Total assets                             $     180,664  $     354,144
                                               =============  =============

Liabilities and Stockholders' Equity
  Accounts payable and accrued liabilities     $     200,589  $     180,244
    Cash overdraft                                         -              -
  Deferred revenues                                    6,894          9,855
                                               -------------  -------------
      Total Current Liabilities                      207,483        190,099


Stockholders' Equity
Preferred stock, $.0001 par value: 10,000,000
 authorized, no shares issued and outstanding              -              -
    Common stock, $.0001 par value:
     75,000,000,000 authorized; 4,019,830,281
     and 3,958,258,852 shares issued and
     outstanding on December 31, 2011 and
     2010, respectively                              401,983        395,826
    Common stock payable                                   -         24,000
    Additional paid in capital                    18,046,851     17,986,149
  Accumulated deficit                            (18,475,653)   (18,241,930)
                                               -------------  -------------
      Total stockholders' equity                     (26,819)       164,045
                                               -------------  -------------
        Total liability and stockholders'
         equity                                $     180,664  $     354,144
                                               =============  =============



                        MEDEFILE INTERNATIONAL, INC.
                           STATEMENT OF OPERATIONS
                                 (Unaudited)


                                            For the Three    For the Three
                                                Months           Months
                                                Ended            Ended
                                              March 31,        March 31,
                                                 2012             2011
                                           ---------------  ---------------
Revenue                                    $        13,714  $       132,102

Cost of goods sold                                      66           63,475
                                           ---------------  ---------------
Gross profit                                        13,648           68,627

Operating expenses
  Selling, general and administrative
   expenses                                        239,774          379,120
  Marketing expense                                      -          129,854
  Depreciation and amortization expense              7,597            7,846
                                           ---------------  ---------------
    Total operating expenses                       247,371          516,820

    Loss from operations                          (233,723)        (448,193)

Other income (expenses)                                  -                -
                                           ---------------  ---------------

Loss before income tax                            (233,723)        (448,193)
  Provision for income tax                               -                -
                                           ---------------  ---------------
Net loss                                   $      (233,723) $      (448,193)
                                           ===============  ===============

Net loss per share: basic and diluted      $         (0.00) $         (0.00)
                                           ===============  ===============

Weighted average share outstanding basic
 and diluted                                 3,977,538,217    3,450,021,410
                                           ===============  ===============

About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has developed and globally markets a proprietary, patient-centric, iPHR (Internet-enabled Personal Health Record) system for gathering, digitizing and organizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is its web-based MedeFile solution, a highly secure system for gathering, maintaining, accessing and sharing personal medical records. Interoperable with most electronic medical record management systems marketed to the healthcare industry, the MedeFile solution is designed to gather all of its members' actual medical records and create a single, comprehensive Electronic Health Record (EHR) that is accessible 24 hours a day, seven days a week by the member and the member's authorized users on any web-enabled device (PC, cell phone, smartphone, e-reader) and portable MedeDrive unit. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com. You can also follow the Company on Facebook!

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.

Add to Digg Bookmark with del.icio.us Add to Newsvine